Multiplexed Assessment of the Southwest Oncology Group-Directed Intergroup Breast Cancer Trial S9313 by AQUA Shows that Both High and Low Levels of HER2 Are Associated with Poor Outcome

This publication has 52 references indexed in Scilit:

• Outcome of Patients With Early-Stage Breast Cancer Treated With Doxorubicin-Based Adjuvant Chemotherapy As a Function of HER2 and TOP2A Status
  Journal of Clinical Oncology, 2009
• Chemosensitivity and Stratification by a Five Monoclonal Antibody Immunohistochemistry Test in the NSABP B14 and B20 Trials
  Clinical Cancer Research, 2008
• American Society of Clinical Oncology 2007 Update of Recommendations for the Use of Tumor Markers in Breast Cancer
  Journal of Clinical Oncology, 2007
• Layered Peptide Array for Multiplex Immunohistochemistry
  The Journal of Molecular Diagnostics, 2007
• The Triple Negative Paradox: Primary Tumor Chemosensitivity of Breast Cancer Subtypes
  Clinical Cancer Research, 2007
• American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer
  Journal of Clinical Oncology, 2007
• p27 Kip1 and Cyclin E Expression and Breast Cancer Survival After Treatment With Adjuvant Chemotherapy
  JNCI Journal of the National Cancer Institute, 2006
• Immunohistochemical and Clinical Characterization of the Basal-Like Subtype of Invasive Breast Carcinoma
  Clinical Cancer Research, 2004
• Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications
  Proceedings of the National Academy of Sciences, 2001
• Progesterone Receptors as a Prognostic Factor in Stage II Breast Cancer
  New England Journal of Medicine, 1983